Multicenter, observational, descriptive study of the diagnosis, course and treatment of patients with SLE in routine practice in Kazakhstan: a registry study with retrospective and prospective components.

Trial Identifier: D3461R00087
Sponsor: AstraZeneca
Start Date: March 2025
Primary Completion Date: September 2026
Study Completion Date: September 2026

Available Languages

For questions about your Trial Results Summary, please see Sponsor contact section within your Trial Results Summary.

No documents have been posted yet.

Trial Locations

No locations posted.